228 related articles for article (PubMed ID: 18191310)
1. Amount of maternal rotavirus-specific antibodies influence the outcome of rotavirus vaccination of newborn mice with virus-like particles.
Johansson E; Istrate C; Charpilienne A; Cohen J; Hinkula J; Poncet D; Svensson L; Johansen K
Vaccine; 2008 Feb; 26(6):778-85. PubMed ID: 18191310
[TBL] [Abstract][Full Text] [Related]
2. Efficient intranasal immunization of newborn mice with recombinant adenovirus expressing rotavirus protein VP4 against oral rotavirus infection.
Liu X; Yang T; Sun QM; Sun MS
Acta Virol; 2005; 49(1):17-22. PubMed ID: 15929394
[TBL] [Abstract][Full Text] [Related]
3. Rectal immunization with rotavirus virus-like particles induces systemic and mucosal humoral immune responses and protects mice against rotavirus infection.
Parez N; Fourgeux C; Mohamed A; Dubuquoy C; Pillot M; Dehee A; Charpilienne A; Poncet D; Schwartz-Cornil I; Garbarg-Chenon A
J Virol; 2006 Feb; 80(4):1752-61. PubMed ID: 16439532
[TBL] [Abstract][Full Text] [Related]
4. Intrarectal immunization with rotavirus 2/6 virus-like particles induces an antirotavirus immune response localized in the intestinal mucosa and protects against rotavirus infection in mice.
Agnello D; Hervé CA; Lavaux A; Darniot M; Guillon P; Charpilienne A; Pothier P
J Virol; 2006 Apr; 80(8):3823-32. PubMed ID: 16571799
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of plant-based rotavirus VP6 induces antigen-specific IgAs, IgGs and passive protection in mice.
Zhou B; Zhang Y; Wang X; Dong J; Wang B; Han C; Yu J; Li D
Vaccine; 2010 Aug; 28(37):6021-7. PubMed ID: 20637305
[TBL] [Abstract][Full Text] [Related]
6. Host, viral, and vaccine factors that determine protective efficacy induced by rotavirus and virus-like particles (VLPs).
Blutt SE; Warfield KL; O'Neal CM; Estes MK; Conner ME
Vaccine; 2006 Feb; 24(8):1170-9. PubMed ID: 16191453
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity to rotavirus-induced diarrhoea is passively transferred to newborn mice from naive dams vaccinated with a single dose of a recombinant adenovirus expressing rotavirus VP7sc.
Both GW; Lockett LJ; Janardhana V; Edwards SJ; Bellamy AR; Graham FL; Prevec L; Andrew ME
Virology; 1993 Apr; 193(2):940-50. PubMed ID: 8384761
[TBL] [Abstract][Full Text] [Related]
8. Parenteral administration of RF 8-2/6/7 rotavirus-like particles in a one-dose regimen induce protective immunity in mice.
Istrate C; Hinkula J; Charpilienne A; Poncet D; Cohen J; Svensson L; Johansen K
Vaccine; 2008 Aug; 26(35):4594-601. PubMed ID: 18588935
[TBL] [Abstract][Full Text] [Related]
9. Nasal immunization of mice with a rotavirus DNA vaccine that induces protective intestinal IgA antibodies.
García-Díaz A; López-Andújar P; Rodríguez Díaz J; Montava R; Torres Barceló C; Ribes JM; Buesa J
Vaccine; 2004 Dec; 23(4):489-98. PubMed ID: 15530697
[TBL] [Abstract][Full Text] [Related]
10. Active immunity against rotavirus infection in mice is correlated with viral replication and titers of serum rotavirus IgA following vaccination.
McNeal MM; Broome RL; Ward RL
Virology; 1994 Nov; 204(2):642-50. PubMed ID: 7941332
[TBL] [Abstract][Full Text] [Related]
11. Oral and intraperitoneal immunization with rotavirus 2/6 virus-like particles stimulates a systemic and mucosal immune response in mice.
Shuttleworth G; Eckery DC; Awram P
Arch Virol; 2005 Feb; 150(2):341-9. PubMed ID: 15578236
[TBL] [Abstract][Full Text] [Related]
12. Oral immunization of mice with Lactococcus lactis expressing the rotavirus VP8* protein.
Rodríguez-Díaz J; Montava R; Viana R; Buesa J; Pérez-Martínez G; Monedero V
Biotechnol Lett; 2011 Jun; 33(6):1169-75. PubMed ID: 21302132
[TBL] [Abstract][Full Text] [Related]
13. Maternal antibodies to rotavirus: could they interfere with live rotavirus vaccines in developing countries?
Chan J; Nirwati H; Triasih R; Bogdanovic-Sakran N; Soenarto Y; Hakimi M; Duke T; Buttery JP; Bines JE; Bishop RF; Kirkwood CD; Danchin MD
Vaccine; 2011 Feb; 29(6):1242-7. PubMed ID: 21147127
[TBL] [Abstract][Full Text] [Related]
14. Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice.
Marelli B; Perez AR; Banchio C; de Mendoza D; Magni C
J Virol Methods; 2011 Jul; 175(1):28-37. PubMed ID: 21530589
[TBL] [Abstract][Full Text] [Related]
15. Transplacental rotavirus IgG interferes with immune response to live oral rotavirus vaccine ORV-116E in Indian infants.
Appaiahgari MB; Glass R; Singh S; Taneja S; Rongsen-Chandola T; Bhandari N; Mishra S; Vrati S
Vaccine; 2014 Feb; 32(6):651-6. PubMed ID: 24374502
[TBL] [Abstract][Full Text] [Related]
16. Distribution and phenotype of rotavirus-specific B cells induced during the antigen-driven primary response to 2/6 virus-like particles administered by the intrarectal and the intranasal routes.
Di Martino C; Basset C; Ogier A; Charpilienne A; Poncet D; Kohli E
J Leukoc Biol; 2007 Oct; 82(4):821-8. PubMed ID: 17652448
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of immune response to bovine rotavirus following oral and intraperitoneal inoculation in mice.
Rathi R; Kadian SK; Khurana B; Grover YP; Gulati BR
Indian J Exp Biol; 2007 Feb; 45(2):212-6. PubMed ID: 17375563
[TBL] [Abstract][Full Text] [Related]
18. Reductions in cross-neutralizing antibody responses in infants after attenuation of the human rotavirus vaccine candidate 89-12.
Ward RL; Kirkwood CD; Sander DS; Smith VE; Shao M; Bean JA; Sack DA; Bernstein DI
J Infect Dis; 2006 Dec; 194(12):1729-36. PubMed ID: 17109346
[TBL] [Abstract][Full Text] [Related]
19. Passive protection to bovine rotavirus (BRV) infection induced by a BRV VP8* produced in plants using a TMV-based vector.
Pérez Filgueira DM; Mozgovoj M; Wigdorovitz A; Dus Santos MJ; Parreño V; Trono K; Fernandez FM; Carrillo C; Babiuk LA; Morris TJ; Borca MV
Arch Virol; 2004 Dec; 149(12):2337-48. PubMed ID: 15338319
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of local immunity and protection in mice by intramuscular immunization with triple- or double-layered rotavirus particles and QS-21.
McNeal MM; Rae MN; Conner ME; Ward RL
Virology; 1998 Mar; 243(1):158-66. PubMed ID: 9527925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
